Rice U. bioengineers developed a platform that enhances survival and function of probiotics engineered to diagnose inflammatory bowel disease in animals. The technology holds promise for minimally invasive disease monitoring and advanced smart therapeutics.
Rice University chemist Han Xiao has won a $3.2 million research project (R01) grant from the National Cancer Institute to develop the first tissue-specific epigenetic inhibitor drug to treat bone metastasis.
Synthetic biologists from Rice University and Princeton University have demonstrated “live reporter” technology that can reveal the workings of signaling networks in living cells with far greater precision than current methods. The first-of-its-kind reporting tool can show how quickly signaling networks respond and how responses vary from cell to cell in time and space.
Rice bioscientist James Chappell has won a National Science Foundation CAREER Award to develop RNA programming methods that can improve human health and the environment.
Rice synthetic biologists have uncovered new capabilities of a genetically encoded sensor that allows salmonella, E. coli and other pathogens to sicken millions of people each year.
Rice University receives National Science Foundation support to turn living cells, starting with bacteria, into random-access memory devices. These will be able to store and report data about their environments.
The Provost’s Office and the Liu Idea Lab for Innovation & Entrepreneurship (Lilie) have announced the inaugural class of Rice Innovation Fellows, a program that will provide educational and financial support to the next generation of scientist- and engineer-led spinout ventures.
Researchers from Rice University and Baylor College of Medicine have shown that colored light can both activate and deactivate genes of gut bacteria in the intestines of worms. The research shows how optogenetic technology can be used to investigate the health impacts of gut bacteria.